Anavex Life Sciences Corp (AVXL)

[sokol]

“The ANAVEX®2-73 Phase 2b/3 study design incorporates genomic precision medicine biomarkers identified in the ANAVEX®2-73 Phase 2a study.”

https://www.anavex.com/press-releases/first-patient-enrolled-in-anavex-life-sciences-phase-2b%2F3-clinical-trial-of-anavex%C2%AE2-73-for-the-treatment-of-early-alzheimer%E2%80%99s-disease